CRYO-CELL INTERNATIONAL, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $601.69 thousand for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-05-31 was $554.59K, a 55.88% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-02-28 was $47.11K, a 83.35% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-11-30 was -$3.82M.
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-08-31 was $749.41K, a 28.74% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$2.43M, a 704.18% decline from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was $402.10K.
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$9.52M, a 443.57% decline from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was $2.77M, a 33.02% increase from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-05-31 | $554.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $601.69K 10-Q · filed 2026-07-15 | -$3.22M derived: sum of 3 quarters · filed 2026-07-15 | -$2.47M derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-02-28 | $47.11K 10-Q · filed 2026-04-14 | -$3.77M derived: sum of 2 quarters · filed 2026-04-14 | -$3.02M derived: sum of 3 quarters · filed 2026-04-14 | -$2.67M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-11-30 | -$3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$3.07M derived: sum of 2 quarters · filed 2026-02-27 | -$2.71M derived: sum of 3 quarters · filed 2026-07-15 | -$2.43M 10-K · filed 2026-02-27 |
| 2025-08-31 | $749.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $1.11M derived: sum of 2 quarters · filed 2026-07-15 | $1.39M 10-Q · filed 2025-10-15 | -$473.57K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-05-31 | $355.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $638.64K 10-Q · filed 2026-07-15 | -$1.22M derived: sum of 3 quarters · filed 2026-07-15 | -$171.30K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-02-28 | $282.86K 10-Q · filed 2026-04-14 | -$1.58M derived: sum of 2 quarters · filed 2026-04-14 | -$527.08K derived: sum of 3 quarters · filed 2026-04-14 | $128.71K derived: sum of 4 quarters · filed 2026-04-14 |
| 2024-11-30 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$809.94K derived: sum of 2 quarters · filed 2026-02-27 | -$154.15K derived: sum of 3 quarters · filed 2026-02-27 | $402.10K 10-K · filed 2026-02-27 |
| 2024-08-31 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $1.71M derived: sum of 2 quarters · filed 2025-10-15 | $2.26M 10-Q · filed 2025-10-15 | -$8.93M derived: sum of 4 quarters · filed 2025-10-15 |
| 2024-05-31 | $655.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | $1.21M 10-Q · filed 2025-07-15 | -$9.98M derived: sum of 3 quarters · filed 2025-07-15 | -$9.30M derived: sum of 4 quarters · filed 2025-07-15 |
| 2024-02-29 | $556.24K 10-Q · filed 2025-04-14 | -$10.63M derived: sum of 2 quarters · filed 2025-04-14 | -$9.95M derived: sum of 3 quarters · filed 2025-04-14 | -$9.73M derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | -$11.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$10.51M derived: sum of 2 quarters · filed 2025-02-28 | -$10.29M derived: sum of 3 quarters · filed 2025-02-28 | -$9.52M 10-K · filed 2025-02-28 |
| 2023-08-31 | $680.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-15 | $901.54K derived: sum of 2 quarters · filed 2024-10-15 | $1.67M 10-Q · filed 2024-10-15 | $2.51M derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $220.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-15 | $987.79K 10-Q · filed 2024-07-15 | $1.83M derived: sum of 3 quarters · filed 2024-07-15 | $2.29M derived: sum of 4 quarters · filed 2024-07-15 |
| 2023-02-28 | $766.81K 10-Q · filed 2024-04-15 | $1.60M derived: sum of 2 quarters · filed 2024-04-15 | $2.07M derived: sum of 3 quarters · filed 2024-04-15 | $2.71M derived: sum of 4 quarters · filed 2024-04-15 |
| 2022-11-30 | $837.82K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.30M derived: sum of 2 quarters · filed 2024-02-28 | $1.94M derived: sum of 3 quarters · filed 2024-02-28 | $2.77M 10-K · filed 2024-02-28 |
| 2022-08-31 | $466.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-12 | $1.10M derived: sum of 2 quarters · filed 2023-10-12 | $1.93M 10-Q · filed 2023-10-12 | $1.30M derived: sum of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | $634.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-14 | $1.47M 10-Q · filed 2023-07-14 | $829.57K derived: sum of 3 quarters · filed 2023-07-14 | $1.69M derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | $832.05K 10-Q · filed 2023-04-21 | $194.85K derived: sum of 2 quarters · filed 2023-04-21 | $1.05M derived: sum of 3 quarters · filed 2023-04-21 | $2.22M derived: sum of 4 quarters · filed 2023-04-21 |
| 2021-11-30 | -$637.19K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $219.30K derived: sum of 2 quarters · filed 2023-02-28 | $1.39M derived: sum of 3 quarters · filed 2023-02-28 | $2.08M 10-K · filed 2023-02-28 |
| 2021-08-31 | $856.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-18 | $2.03M derived: sum of 2 quarters · filed 2022-10-18 | $2.72M 10-Q · filed 2022-10-18 | $3.92M derived: sum of 4 quarters · filed 2022-10-18 |
| 2021-05-31 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-11 | $1.86M 10-Q · filed 2022-07-11 | $3.06M derived: sum of 3 quarters · filed 2022-07-11 | $3.85M derived: sum of 4 quarters · filed 2022-07-11 |
| 2021-02-28 | $693.59K 10-Q · filed 2022-04-13 | $1.89M derived: sum of 2 quarters · filed 2022-04-13 | $2.68M derived: sum of 3 quarters · filed 2022-04-13 | $3.63M derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-11-30 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.98M derived: sum of 2 quarters · filed 2022-02-22 | $2.94M derived: sum of 3 quarters · filed 2022-02-22 | $3.62M 10-K · filed 2022-02-22 |
| 2020-08-31 | $784.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-15 | $1.74M derived: sum of 2 quarters · filed 2021-10-15 | $2.42M 10-Q · filed 2021-10-15 | $3.27M derived: sum of 4 quarters · filed 2021-10-15 |
| 2020-05-31 | $953.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-15 | $1.64M 10-Q · filed 2021-07-15 | $2.49M derived: sum of 3 quarters · filed 2021-07-15 | $3.60M derived: sum of 4 quarters · filed 2021-07-15 |
| 2020-02-29 | $686.97K 10-Q · filed 2021-04-14 | $1.53M derived: sum of 2 quarters · filed 2021-04-14 | $2.65M derived: sum of 3 quarters · filed 2021-04-14 | $2.70M derived: sum of 4 quarters · filed 2021-04-14 |
| 2019-11-30 | $844.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.96M derived: sum of 2 quarters · filed 2021-03-01 | $2.01M derived: sum of 3 quarters · filed 2021-03-01 | $2.29M 10-K · filed 2021-03-01 |
| 2019-08-31 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-15 | $1.17M derived: sum of 2 quarters · filed 2020-10-15 | $1.45M 10-Q · filed 2020-10-15 | $2.34M derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-05-31 | $53.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-10 | $329.55K 10-Q · filed 2020-07-10 | $1.22M derived: sum of 3 quarters · filed 2020-07-10 | $1.47M derived: sum of 4 quarters · filed 2020-07-10 |
| 2019-02-28 | $275.88K 10-Q · filed 2020-04-14 | $1.17M derived: sum of 2 quarters · filed 2020-04-14 | $1.41M derived: sum of 3 quarters · filed 2020-04-14 | $1.95M derived: sum of 4 quarters · filed 2020-04-14 |
| 2018-11-30 | $890.76K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.14M derived: sum of 2 quarters · filed 2020-02-28 | $1.68M derived: sum of 3 quarters · filed 2020-02-28 | -$854.82K 10-K · filed 2020-02-28 |
| 2018-08-31 | $244.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-15 | $784.49K derived: sum of 2 quarters · filed 2019-10-15 | -$1.75M 10-Q · filed 2019-10-15 | |
| 2018-05-31 | $539.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-15 | -$1.99M 10-Q · filed 2019-07-15 | ||
| 2018-02-28 | -$2.53M 10-Q · filed 2019-04-15 | |||
| 2017-11-30 | $2.32M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |